ANTI-ALLERGIC VACCINE

摘要

A vaccine composition useful for treating or preventing immunoglobulin E mediated type 1 hypersensitivity reactions and inflammatory immune diseases, and for modulating IgE synthesis. Specific antibodies induced by the immunogen of the vaccine composition, the immunogen used and a method for preparing same, are also disclosed. The immunogen is a non-glycosylated or partially glycosylated polypeptide derived from the Fc fragment of human or primate IgE.